10/24/2011
CW Weekly- The Pulse on Recruitment- Bacterial Vaginosis
On a recent multi-center Bacterial Vaginosis study, based upon very specific strategic, upfront, communications planning, TKL not only contributed significantly more patients than originally projected, but did so in less than 15% of the sponsor's projected enrollment timeline.
|
|
|
|
|
|
5/11/2011
TKL Research to Present at the MAGI Clinical Research Conference
TKL Research, a full-service international CRO focused on Phase 1-4 clinical trials is pleased to announce that key team members will deliver presentations at the MAGI Clinical Research Conference which highlight effective budget development, negotiations, cost-saving measures and methodologies to consistently maximize revenue.
|
|
|
|
3/7/2011
CW Weekly- The Pulse on Recruitment- Psoriasis
On a recent large scale multi-center psoriasis study, through its patient recruitment management efforts, TKL not only contributed significantly more patients than originally projected, but did so in half of the sponsor's projected enrollment timeline.
|
|
6/8/2010
TKL Research Expands Capability in Europe
TKL Research, (www.tklresearch.com) a fullservice US-based clinical research organization (CRO) that focuses on enrollment-driven Phase I-IV clinical trials announced an expansion of its presence and capabilities in Europe by taking an equity position in proinnovera GmbH, a full-service CRO based in Münster, Germany.
|
|
|
|
